Genitourinary Cancer,Other Cancers PARP1 and PBRM1 as Biomarkers for Atezolizumab Plus Bevacizumab or Sunitinib Response in RCC May 08, 2023
Genitourinary Cancer,Prostate Cancer COMET-2 Trial: Treatment Tolerance With Patient-Reported Outcomes Data and Toxicity Index Evaluated May 03, 2023
Genitourinary Cancer,Prostate Cancer A Phase 2 Study on Oral Docetaxel + Ritonavir for mCRPC May 03, 2023
Genitourinary Cancer,Prostate Cancer ENACT Trial: Enzalutamide for Localized Prostate Cancer May 03, 2023
Genitourinary Cancer,Prostate Cancer ODM-208 for Metastatic Castration-resistant Prostate Cancer: Safety and Pharmacokinetics Study May 02, 2023
Genitourinary Cancer,Prostate Cancer Improving Prostate Cancer Treatment: The Impact of DCVAC/PCa and Chemotherapy on mCRPC May 02, 2023
Genitourinary Cancer,Prostate Cancer Enzalutamide Plus ADT vs Placebo Plus ADT in mHSPC: A Network Meta-Analysis May 02, 2023
Genitourinary Cancer,Prostate Cancer Enhancing PBRT with ADT and Pelvic Lymph Node Treatment May 02, 2023
